<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The complexity of the several pathogenic pathways that cause <z:hpo ids='HP_0000822'>hypertension</z:hpo> and <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> and the prolonged interval that appears to predate clinical morbidity have hindered inquiry into the association between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> and <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disorders</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>As a forme fruste of later type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e>-affected gravidas are identified as at risk of <z:mp ids='MP_0002055'>diabetes</z:mp>-related <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, glomerular disruption, and pathogenic <z:chebi fb="46" ids="15035">retinal</z:chebi> angio-genesis </plain></SENT>
<SENT sid="2" pm="."><plain>That <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> is evidence for underlying <z:hpo ids='HP_0011010'>chronic</z:hpo> conditions such as dysregulation of innate immune response that, independent of the diabetic state, produces <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> is difficult state, produces <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> is difficult to assert with the present published literature </plain></SENT>
<SENT sid="3" pm="."><plain>Cross-sectional studies of patients with established gestational <z:hpo ids='HP_0000822'>hypertension</z:hpo> or <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e> are ambiguous as to the possible pathogenic effect of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Cohort studies initiated in early and mid-pregnancy show evidence that both gestational <z:hpo ids='HP_0000822'>hypertension</z:hpo> and <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e> may be more prevalent in gravidas with greater <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The association of gestational <z:hpo ids='HP_0000833'>glucose intolerance</z:hpo> with gestational <z:hpo ids='HP_0000822'>hypertension</z:hpo> appears to be independent of <z:hpo ids='HP_0001513'>obesity</z:hpo> and ambient glycemia but explained in part by <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0878751" disease_type="Disease or Syndrome" abbrv="">Late pregnancy</z:e> <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e> is associated with elevated mid-pregnancy BMI, blood pressure, fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> and insulin, urate, and C-reactive protein, suggestive of metabolic and <z:hpo ids='HP_0002958'>immune dysregulation</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> appears to be associated with overexpressed innate immune response, which, in turn, is associated with vascular dysfunction and <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Among women with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e>, markers of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> do not appear to correlate with <z:hpo ids='HP_0000822'>hypertension</z:hpo> in short-term cohort studies </plain></SENT>
<SENT sid="9" pm="."><plain>However, when non-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> subjects are compared with subjects with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e>, postpregnancy studies do show an associated with vascular dysfunction and <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Among women with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e>, markers of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> do not appear to correlate with <z:hpo ids='HP_0000822'>hypertension</z:hpo> in short-term cohort studies </plain></SENT>
<SENT sid="11" pm="."><plain>However, when non-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> subjects are compared with subjects with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e>, postpregnancy studies do show an association of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> with both inflammatory dysregulation and vascular dysfunction </plain></SENT>
<SENT sid="12" pm="."><plain>Cohort studies that have used population-based pregnancy databases consistently identify a clinically significant association of both gestational <z:hpo ids='HP_0000822'>hypertension</z:hpo> and <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e> with later <z:e sem="disease" ids="C0020538" disease_type="Disease or Syndrome" abbrv="HTN">hypertensive disorders</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>Associations with <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> or <z:hpo ids='HP_0001297'>stroke</z:hpo> are less consistent, requiring further investigation </plain></SENT>
<SENT sid="14" pm="."><plain>Preventing the evolution of <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:chebi fb="23" ids="18059">lipid</z:chebi> and <z:hpo ids='HP_0002958'>immune dysregulation</z:hpo> of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> has become a silent public health issue because of the epidemic of childhood and early adulthood <z:hpo ids='HP_0001513'>obesity</z:hpo> and the opportunity at hand to treat <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> by behavioral and pharmacological interventions </plain></SENT>
<SENT sid="15" pm="."><plain>However, limited available literature highlights the need for long-term cohort studies of women with well-characterized metabolic and vascular profiles during pregnancy and decades later </plain></SENT>
<SENT sid="16" pm="."><plain>Our present knowledge suggests that screening for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> provides an opportunity of pregnancy outcome improvement </plain></SENT>
<SENT sid="17" pm="."><plain>Limited studies of <z:mp ids='MP_0002055'>diabetes</z:mp> prevention in at-risk patient groups suggest that we may have the opportunity to reduce the risk of later <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="18" pm="."><plain>Additional investigation is required to determine if interventions that prevent or postpone <z:mp ids='MP_0002055'>diabetes</z:mp> also delay the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> </plain></SENT>
</text></document>